Covid vaccine: Ecuador envoy hails Indian companies, takes part in trials

Published on Jan 09, 2021 03:57 pm IST

Hector Cueva Jacome, the Ecuadorian ambassador to India, participated in clinical trials of the Covaxin vaccine, developed by Bharat Biotech. He said that he researched about the vaccine and then arrived at the decision to take part in the trials. He received the first dose in Rohtak, and is slated to receive the second after 28 days. Two weeks after that, he would be told if he got the actual vaccine or a placebo. Jacome hailed Indian vaccine-makers Bharat Biotech and Serum Institute of India. The two are manufacturing vaccines recently cleared by Indian drug regulators. Watch the full video for more.

RELATED VIDEOS

NYC Mayor Mamdani Drops the 'Cutest' Announcement Ever, In Bengali, With Free Broadway Seats

0:33
NYC Mayor Mamdani Drops the 'Cutest' Announcement Ever, In Bengali, With Free Broadway Seats
Published on Aug 17, 2026 02:58 pm IST

Baba Budha Amarnath Yatra Begins From Jammu Base Camp Amid Tight Security Arrangements

1:07
Baba Budha Amarnath Yatra Begins From Jammu Base Camp Amid Tight Security Arrangements
Published on Aug 17, 2026 02:43 pm IST

Iran’s top negotiator declares victory over US & Israel, calls…

10:36
Iran’s top negotiator declares victory over US & Israel, calls…
Published on Aug 17, 2026 02:01 pm IST

Jakarta Celebrates Indonesia's 81st Independence Day Amid Earthquake Recovery Efforts

1:07
Jakarta Celebrates Indonesia's 81st Independence Day Amid Earthquake Recovery Efforts
Published on Aug 17, 2026 01:58 pm IST

CENTCOM chief hails USS Lincoln crew but exposes the state of US carriers?

8:6
CENTCOM chief hails USS Lincoln crew but exposes the state of US carriers?
Published on Aug 17, 2026 01:55 pm IST

Zelensky's biggest drone war backfires as Russia downs 822 UAVs, then hits back

8:11
Zelensky's biggest drone war backfires as Russia downs 822 UAVs, then hits back
Published on Aug 17, 2026 01:53 pm IST
Hindustantimes wants to start sending you push notifications. Click allow to subscribe